Australia - English - Department of Health (Therapeutic Goods Administration)

novo nordisk pharmaceuticals pty ltd - somatropin -

Australia - English - Department of Health (Therapeutic Goods Administration)

novo nordisk pharmaceuticals pty ltd - somatropin -

Australia - English - Department of Health (Therapeutic Goods Administration)

novo nordisk pharmaceuticals pty ltd - somatropin -

Israel - English - Ministry of Health

novo nordisk ltd., israel - somatropin - solution for injection - somatropin 3.3 mg / 1 ml - somatropin - somatropin - children: short stature due to inadequate or failed secretion of pituitary growth hormone or turner`s syndrome. short stature in children with renal insufficiency. growth disturbance (current height sds < - 2.5 and parental adjusted height sds < - 1) in short children born small for gestational age (sga) with a birth weight and/or length below - 2 sd who failed to show catch-up growth (hv sds < during the last year) by 4 years of age or later.children with short stature associated with noonan syndrome.adults: treatment of adults with hypothalamic-pituitary disease resulting from organic disease or pituitary tumors treated medically surgically or radiotherapy or patients with chilhood onset of g.h. deficiency. תוספת התוויה: 5/6/2019indication:children: short stature due to inadequate or failed secretion of pituitary growth hormone or turner`s syndrome.short stature in children with renal insufficiency.growth disturbance (current height sds < -2.5 and parental adjusted height sds < -1) in short childre

Canada - English - Health Canada

novo nordisk canada inc - somatropin - solution - 5mg - somatropin 5mg - pituitary

Canada - English - Health Canada

novo nordisk canada inc - somatropin - solution - 10mg - somatropin 10mg - pituitary

Canada - English - Health Canada

novo nordisk canada inc - somatropin - solution - 15mg - somatropin 15mg - pituitary